| Page 1937 | Kisaco Research
Animal Microbiome USA- 7 Benefits of Attending
North American Microbiome Congress Post Show Report
 

Marc Cartellieri

Chief Scientific Officer
Cellex Patient Treatment

Marc Cartellieri

Chief Scientific Officer
Cellex Patient Treatment

Marc Cartellieri

Chief Scientific Officer
Cellex Patient Treatment
 

Dr David Sourdive

Executive Vice President Technical Operations
Cellectis

Dr David Sourdive

Executive Vice President Technical Operations
Cellectis

Dr David Sourdive

Executive Vice President Technical Operations
Cellectis
 

Stefano Baila

Former Process Development Manager
Holding F.I.S.

Stefano Baila

Former Process Development Manager
Holding F.I.S.

Stefano Baila

Former Process Development Manager
Holding F.I.S.
 

Michaela Sharpe

Head of Non-Clinical Safety and Immunotherapy Strategy
Cell & Gene Therapy Catapult

Michaela Sharpe

Head of Non-Clinical Safety and Immunotherapy Strategy
Cell & Gene Therapy Catapult

Michaela Sharpe

Head of Non-Clinical Safety and Immunotherapy Strategy
Cell & Gene Therapy Catapult
 

Sarah Snykers

QC Manager
Celyad

Sarah Snykers

QC Manager
Celyad

Sarah Snykers

QC Manager
Celyad
 

Michaela Sharpe

Head of Non-Clinical Safety and Immunotherapy Strategy
Cell & Gene Therapy Catapult

Michaela Sharpe

Head of Non-Clinical Safety and Immunotherapy Strategy
Cell & Gene Therapy Catapult

Michaela Sharpe

Head of Non-Clinical Safety and Immunotherapy Strategy
Cell & Gene Therapy Catapult